Capmaxen 200 mg| Capmatinib Cost| Capmatinib package insert

Capmaxen 200 mg is used for the treatment of metastatic non-small lung cancer (NSCLC). It is prescribed for adults and when their tumors have a mutation known as mesenchymal-epithelial transition (MET) exon 14 skipping.  This mutation must be confirmed through an FDA-approved test for the medication to be used.